CD84 is a Suppressor of T and B Cell Activation during Mycobacterium tuberculosis Pathogenesis

Interest in host-directed therapies as alternatives/adjuncts to antibiotic treatment has resurged with the increasing prevalence of antibiotic-resistant tuberculosis (TB). Immunotherapies that reinvigorate immune responses by targeting immune checkpoints like PD-1/PD-L1 have proved successful in can...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Nan, Fleming, Joy, Hu, Peilei, Jiao, Jianjian, Zhang, Guoqin, Yang, Ruifang, Li, Chuanyou, Liu, Yi, Bi, Lijun, Zhang, Hongtai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865571/
https://www.ncbi.nlm.nih.gov/pubmed/35196822
http://dx.doi.org/10.1128/spectrum.01557-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865571/
https://www.ncbi.nlm.nih.gov/pubmed/35196822
http://dx.doi.org/10.1128/spectrum.01557-21

Ejemplares similares